Overview

Our
Products

NorthStar uses non-uranium based processes to produce the vitally important medical radioisotope, molybdenum-99 (Mo-99) here in the United States. Mo-99 enables the RadioGenix® System (technetium Tc 99m generator) to produce technetium-99m (Tc-99m), the most widely used medical radioisotope.

PRODUCING Mo-99
REQUIRES SOLUTIONS
THAT ARE

SOLVING THE
SUPPLY CHALLENGE

Until now, radiopharmacies in the United States have had to rely on overseas producers for medical radioisotopes critical to patient care.

A Reliable U.S.
Supply of Mo-99
Requires

INNOVATIVE
Mo-99
PRODUCTION

We revolutionized the production of Mo-99 by launching concentrated molybdenum-99 (cMo-99). This game-changing production method allows for higher activity source vessels without the use of uranium, making Mo-99 more widely available across the U.S.

A Reliable U.S.
Supply of Mo-99
Requires The

rdx logo

Commercially available for over three years, NorthStar’s innovative RadioGenix Systems produce Tc-99m to meet patients’ healthcare needs reliably.

LEVERAGING ADVANCED PROCESSES THAT ARE
ECO FRIENDLY

The advanced technologies employed at NorthStar produce benign and recyclable waste streams that are free of the toxic and radioactive waste associated with uranium-based production. In this way, the Mo-99 produced at NorthStar is significantly more environmentally friendly than current standards.